SERVA ENERGY, INC.
TEMPE, AZ · Founded 2017 · CIK 0001779623 · Biotech
GMP-grade terbium-161 radioisotope for targeted radiotherapeutic drugs
servaenergy.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $7.1M
- 13 Form D · May 2026
- 5 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Private capital raised | Form D · SEC | $125,760 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $550,000 | |
| Private capital raised | Form D · SEC | $25,000 | |
| Private capital raised | Form D · SEC | $700,000 | |
| Private capital raised | Form D · SEC | $130,000 | |
| Private capital raised | Form D · SEC | $2,025,000 | |
| Private capital raised | Form D · SEC | $60,000 | |
| Private capital raised | Form D · SEC | $371,030 | |
| Private capital raised | Form D · SEC | $2,500,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3368 | COLLABORATIONS PHARMACEUTICALS INC | — | — |
| 3369 | Centivax Inc | — | — |
| 3370 | SPERAGEN, INC. | — | — |
| 3371 | SERVA ENERGY, INC. | — | $7.1M |
| 3372 | SwanBio Therapeutics | — | — |
| 3373 | Akston Biosciences Corp | — | $17M |
| 3374 | Aqualung Therapeutics Corp. | — | $3.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Neil AlfordDirector
- Terry AlfordDirector
- Greg AndersonExecutive Officer
- Ian HorvathDirector · Executive Officer
- Ed MurrerDirector
- Neil O'LearyDirector
- Charles RunyanDirector
- Tim VatuoneExecutive Officer
Patents
- Techniques For Producing ACTINIUM-225 And Related Systems And Methodsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.